Bank Of America Corp Anavex Life Sciences Corp. Put Options Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$3.39 - $5.02 $1.32 Million - $1.95 Million	-388,800 Reduced 68.85%	175,900 $742,000
Q1 2024 May 15, 2024	BUY	$4.55 - $6.75 $2.57 Million - $3.81 Million	564,700 New	564,700 $2.87 Million
Q4 2022 Feb 10, 2023	BUY	$7.65 - $14.43 $774,180 - $1.46 Million	101,200 New	101,200 $937,000
Q3 2021 Nov 15, 2021	BUY	$16.82 - $25.75 $16,820 - $25,750	1,000 New	1,000 $18,000

155

27.3M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.